Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
762.70
Change Change %
-13.25 -1.71%

Updated:21 Sep, 2018, 15:59 PM IST

BSE
761.65
Change Change %
-14.05 -1.81%

Updated:21 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
19-03-2015 Buy 1262.10 1945.00
N/A
Closed Custom
19-03-2016

Citi maintains buy on Aurobindo Pharma

Aurobindo Pharma is the top mid-cap pharma pick. Expect strong earnings per share growth for FY14-17. Company has been improving its balance sheet to drive re-rating.

Top